Healthcare stocks were ending narrowly lower Tuesday afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both slipping 0.3%. The iShares Biotechnology ETF (IBB) also was dropping 0.6%.
In company news, CNS Pharmaceuticals (CNSP) slid almost 18% after completing a 1-for-30 reverse split of its common stock as part of efforts by the clinical-stage drug maker to boost its share price above the Nasdaq stock market's $1-per-share minimum price threshold.